Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe AD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of CBP-201 in Chinese adults with moderate to severe atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• CBP-201

Snippet

Sponsor: Connect Biopharm LLC | Conditions: Atopic Dermatitis | Phase 2 | Status: UNKNOWN